Outcomes of colorectal cancer in the United States: No change in survival (1986-1997)

American Journal of Gastroenterology

Volumn 98, Issue 2, 2003, Pages 471-477

  Rabeneck, Linda ^a   El Serag, Hashem B ^b   Davila, Jessica A ^b   Sandler, Robert S ^b  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER REGISTRY; CANCER SCREENING; CANCER SURVIVAL; COLORECTAL CANCER; ETHNIC DIFFERENCE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; SEX DIFFERENCE; SURVIVAL RATE; UNITED STATES;

EID: 0037285705     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(02)05928-2     Document Type: Article

References (31)

1. American Cancer Society. Cancer facts and figures. Atlanta: American. Cancer Society, 2002.
2. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 1993;328:1365-71.
3. Hardcastle JD, Chamberlain JO, Robinson MHE, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996;348:1472-7.
4. Kronberg O, Fenger C, Olsen J, et al. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996;348:1467-71.
5. Mandel JS, Church TR, Bond JH, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 2000;343:1603-7.
6. Selby JV, Friedman GD, Quesenberry CP, et al. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 1992;326:653-7.
7. Newcomb PA, Norfleet RG, Storer BE, et al. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 1992;84:1572-5.
8. Muller AD, Sonnenberg A. Protection by endoscopy against death from colorectal cancer: A case-control study among veterans. Arch Intern Med 1995;155:1741-8.
9. Muller AD, Sonnenberg A. Prevention of colorectal cancer by flexible endoscopy and polypectomy: A case-control study of 32,702 veterans. Ann Intern Med 1995;123:904-10.
10. Winawer SJ, Flehinger BJ, Schottenfeld D, et al, Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy. J Natl Cancer Inst 1993;85:1311-8.
11. Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med 1993;329:1977-81.
12. National Institutes of Health Consensus Conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA 1990;264:1444-50.
13. Brook RH, Lohr KN. Efficacy, effectiveness, variations, and quality. Boundary crossing research. Med Care 1985;23:710-22.
14. Howe HL, Wingo PA, Thun MJ, et al. Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. J Natl Cancer Inst 2001; 93:824-42.
15. Chu KC, Tarone RE, Chow W-H, et al. Temporal patterns in colorectal cancer incidence, survival, and mortality from 1950 through 1990. J Natl Cancer Inst 1994;86:997-1006.
16. Surveillance, Epidemiology, and End Results (SEER) program public-use CD-ROM (1973-1997). Bethesda, MD: National Cancer Institute, 2000 (software).
17. Department of Health and Human Services. The international classification of diseases, 9th revision, clinical modification: ICD-9-CM, 3rd ed, vol 1. Diseases: tabular list. Washington, DC: Government Printing Office, March 1989. (DHHS publication no. (PHS) 89-1260).
18. Percy C, Van Holten V, Muir C. International classification of diseases for oncology, 2nd ed. Geneva: World Health Organization, 1990.
19. Ederer F, Axtell LM, Cutler SJ. The relative survival rate: A statistical methodology. Natl Cancer Inst Monogr 1961;6:101-21.
20. Henson DE, Ries LA. The relative survival rate. Cancer 1995; 76:1687-8.
21. Wingo PA, Ries LA, Parker SL, et al. Long-term cancer patient survival in the United States. Cancer Epidemiol Biomarkers Prev 1998;7:271-82.
22. Ries LA, Wingo PA, Miller DS, et al. The annual report to the nation on the status of cancer, 1973-1997; with a special section on colorectal cancer. Cancer 2000;88:2398-424.
23. Brenner H, Hakulinen T. Long-term cancer patient survival achieved by the end of the 20th century: Most up-to-date estimates from the nationwide Finnish cancer registry. Br J Cancer 2001;85:367-71.
24. Centers for Disease Control and Prevention. Screening for colorectal cancer - United States, 1997. MMWR 1999;48:116-21.
25. Cooper GS, Yuan Z, Landefeld CS, et al. Surgery for colorectal cancer: Race-related differences in rates and survival among Medicare beneficiaries. Am J Public Health 1996;86: 582-6.
26. Hodgson DC, Fuchs CS, Ayanian JZ. Impact of patient and provider characteristics on the treatment and outcomes of colorectal cancer. J Natl Cancer Inst 2001;93:501-15.
27. Shavers VL, Brown M. Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst 2002;94:334-57.
28. Troisi R, Freedman AN, Devesa SS. Incidence of colorectal carcinoma in the U.S. An update of trends by gender, race, age, subsite, and stage, 1975-94.
29. Wu XC, Chen VW, Steele B, et al. Subsite-specific incidence rate and stage of disease in colorectal cancer by race, gender, and age group in the United States, 1997. Cancer 2001;92: 2547-54.
30. Welch HG, Schwartz LM, Woloshin S. Are increasing 5-year survival rates evidence of success against cancer? JAMA 2000;283:2975-8.
31. Centers for Disease Control and Prevention. Trends in screening for colorectal cancer - United States, 1997 and 1999. MMWR 2001;50:162-6.